BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31713617)

  • 1. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
    Lee JS; Lee JY; Song DW; Bae HS; Doo HM; Yu HS; Lee KJ; Kim HK; Hwang H; Kwak G; Kim D; Kim S; Hong YB; Lee JM; Choi BO
    Nucleic Acids Res; 2020 Jan; 48(1):130-140. PubMed ID: 31713617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
    Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.
    Stavrou M; Kagiava A; Choudury SG; Jennings MJ; Wallace LM; Fowler AM; Heslegrave A; Richter J; Tryfonos C; Christodoulou C; Zetterberg H; Horvath R; Harper SQ; Kleopa KA
    J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35579942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of protein quality control mechanisms during disease progression in the C22 mouse model of CMT1A.
    Chittoor VG; Sooyeon L; Rangaraju S; Nicks JR; Schmidt JT; Madorsky I; Narvaez DC; Notterpek L
    ASN Neuro; 2013 Dec; 5(5):e00128. PubMed ID: 24175617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease.
    Kinter J; Lazzati T; Schmid D; Zeis T; Erne B; Lützelschwab R; Steck AJ; Pareyson D; Peles E; Schaeren-Wiemers N
    Neurobiol Dis; 2013 Jan; 49():221-31. PubMed ID: 22940629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
    Sancho S; Young P; Suter U
    Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PMP22 expression in dermal nerve myelin from patients with CMT1A.
    Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
    Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.
    Perea J; Robertson A; Tolmachova T; Muddle J; King RH; Ponsford S; Thomas PK; Huxley C
    Hum Mol Genet; 2001 May; 10(10):1007-18. PubMed ID: 11331611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
    Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
    Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the neuropathy-associated Pmp22 gene by a distal super-enhancer.
    Pantera H; Moran JJ; Hung HA; Pak E; Dutra A; Svaren J
    Hum Mol Genet; 2018 Aug; 27(16):2830-2839. PubMed ID: 29771329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A.
    Gautier B; Hajjar H; Soares S; Berthelot J; Deck M; Abbou S; Campbell G; Ceprian M; Gonzalez S; Fovet CM; Schütza V; Jouvenel A; Rivat C; Zerah M; François V; Le Guiner C; Aubourg P; Fledrich R; Tricaud N
    Nat Commun; 2021 Apr; 12(1):2356. PubMed ID: 33883545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves.
    Pantera H; Hu B; Moiseev D; Dunham C; Rashid J; Moran JJ; Krentz K; Rubinstein CD; Won S; Li J; Svaren J
    Hum Mol Genet; 2020 Jun; 29(10):1689-1699. PubMed ID: 32356557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of PMP22 ameliorates myelin defects in iPSC-derived human organoid cultures of CMT1A.
    Van Lent J; Vendredy L; Adriaenssens E; Da Silva Authier T; Asselbergh B; Kaji M; Weckhuysen S; Van Den Bosch L; Baets J; Timmerman V
    Brain; 2023 Jul; 146(7):2885-2896. PubMed ID: 36511878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMP22 overexpression causes dysmyelination in mice.
    Robaglia-Schlupp A; Pizant J; Norreel JC; Passage E; Sabéran-Djoneidi D; Ansaldi JL; Vinay L; Figarella-Branger D; Lévy N; Clarac F; Cau P; Pellissier JF; Fontés M
    Brain; 2002 Oct; 125(Pt 10):2213-21. PubMed ID: 12244079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroceutical approach ameliorates intracellular PMP22 aggregation and promotes pro-myelinating pathways in a CMT1A in vitro model.
    Intisar A; Woo H; Kang HG; Kim WH; Shin HY; Kim MY; Kim YS; Mo YJ; Lee YI; Kim MS
    Biosens Bioelectron; 2023 Mar; 224():115055. PubMed ID: 36630746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy.
    Meyer zu Hörste G; Prukop T; Nave KA; Sereda MW
    J Mol Neurosci; 2006; 28(1):77-88. PubMed ID: 16632877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
    Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
    Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.